Cornelia Michaelis

Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating

Rainer Wessely, Jörg Hausleiter, Cornelia Michaelis et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 133 citations · Full text

Pharmacy, Bioengineering, Pharmacology +17

Targeting 2A Protease by RNA Interference Attenuates Coxsackieviral Cytopathogenicity and Promotes Survival in Highly Susceptible Mice

Sabine Merl, Cornelia Michaelis, Birgit Jaschke et al. · Circulation · 2005 · 67 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Vascular Remodeling in Mice Lacking the Cytoplasmic Domain of Tissue Factor

Ilka Ott, Cornelia Michaelis, Maren Schuermann et al. · Circulation Research · 2005 · 26 citations

Life Sciences, Cell Biology, Molecular Biology +10

Local cyclin‐dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug‐ eluting stents to prevent neointima formation following vascular injury

Birgit Jaschke, Stefan Milz, Michael Vogeser et al. · The FASEB Journal · 2004 · 23 citations

Medicine, Cardiology, Pharmacology +17

The Ran GTPase-Activating Protein (RanGAP1) Is Critically Involved in Smooth Muscle Cell Differentiation, Proliferation and Migration following Vascular Injury: Implications for Neointima Formation and Restenosis

Marc Vorpahl, Sabine Schönhofer‐Merl, Cornelia Michaelis et al. · PLoS ONE · 2014 · 12 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15